Results 291 to 300 of about 69,426 (314)

Forensic pharmacovigilance: Newer dimension of pharmacovigilance

Journal of Forensic and Legal Medicine, 2015
Drug safety for the patients is of paramount importance for a medical professional. Pharmacovigilance attempts to ensure the safety of patients by keeping a close vigil on the pattern of adverse events secondary to drug use. Number of medicolegal cases is at rise since last few years. Forensic sciences and pharmacovigilance need to work hand in hand to
Rakesh K. Sewal, Vikas K. Saini, Bikash Medhi   +2 more
openaire   +2 more sources

Pharmacovigilance in Perspective

Drug Safety, 1999
Pharmacovigilance is more than spontaneous reporting alone, and the evaluation of marketed medicines is more than just pharmacovigilance. The positioning of a drug usually takes place during the years following introduction, when worldwide experience has accumulated.
Meyboom, R.H.B., Egberts, A.C.G., Gribnau, F.W.J., Hekster, Y.A.   +3 more
openaire   +4 more sources

Pharmacovigilance

Drug Safety, 1990
The French system of drug surveillance (pharmacovigilance) is a combination of mandatory reporting and intensive hospital surveillance. The Regional Centres are decentralised but coordinated through a national network. An algorithm index is used to assess the relationship between drugs and adverse effects. The adverse reactions alert system is produced
openaire   +2 more sources

Pharmacovigilance

2012
Any substance that is capable of producing a therapeutic effect can also produce unwanted or adverse effects. It is important to understand the basic concepts related to Adverse Drug Reactions (ADRs): epidemiology, classification, predisposing factors, evaluation parameters, and surveillance methods.
A. C. van Grootheest, Rachel L. Richesson   +1 more
openaire   +2 more sources

Forensic Pharmacovigilance

International Journal of Risk & Safety in Medicine, 2012
I Ralph, Edwards, David, Body
openaire   +2 more sources

European pharmacovigilance: an overview of pharmacovigilance inspections

Pharmacoepidemiology and Drug Safety, 2005
M C, Koster, A H M, van den Oetelaar
openaire   +2 more sources

Pharmacovigilance

Revue Médicale Suisse, 2013
Joel M. Gelfand, Sinéad M. Langan
  +4 more sources